Cover Image
市場調查報告書

疫苗受託製造的全球市場分析

Vaccine Contract Manufacturing Market Report 2016-2021

出版商 Labrinth Analytics LTD 商品編碼 359780
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
疫苗受託製造的全球市場分析 Vaccine Contract Manufacturing Market Report 2016-2021
出版日期: 2016年05月13日 內容資訊: 英文
簡介

本報告提供全球疫苗受託製造市場相關分析,關於生產技術概要和目前技術水準,整體市場結構,競爭狀態,市場促進、阻礙因素,各地區的市場趨勢預測,主要企業簡介等調查評估。

第1章 過去的市場資料 (過去4年份)

第2章 主要企業

  • Baxter BioPharma Solutions
  • Boehringer Ingelheim
  • Catalent
  • Charles River Laboratories
  • IDT Biologika GmbH
  • Lonza
  • Meridian Life Science
  • Sigma-Aldrich
  • SynCo Bio Partners
  • OSO BioPharmaceuticals Manufacturing
  • 主要的產業團體

第3章 最新的疫苗製造技術

  • 全球生技仿製藥/疫苗受託製造市場
  • 疫苗生產用的新基材
  • 哺乳類細胞株
  • 鳥類衍生細胞株
  • 植物來源疫苗
  • 昆蟲蛋為基礎的生產系統
  • 表現系統及媒介
  • 設備的趨勢
  • 預填充式注射器和疫苗
  • 冷凍乾燥與疫苗製造
  • 保存期限的問題和H1N1疫苗

第4章 主要國家的疫苗受託製造市場 (今後6年份)

  • 亞洲市場:地區整體預測 (今後6年份)
  • 印度市場
  • 中國市場
  • 韓國市場
  • 日本市場
  • 其他的亞洲各國的市場
  • 歐洲市場:地區整體預測 (今後6年份)
  • 俄羅斯市場
  • 德國市場
  • 英國市場
  • 法國市場
  • 義大利市場
  • 其他的歐洲各國的市場
  • 北美市場:地區整體預測 (今後6年份)
  • 美國市場
  • 加拿大市場
  • 南美市場:地區整體預測 (今後6年份)
  • 巴西市場
  • 墨西哥市場
  • 其他的南美各國的市場
  • 其他的國家 (RoW)的市場 (今後6年份)

第5章 疫苗製造市場 (今後6年份)

  • 製藥產業、生物科技產業上外包
  • 受託製造企業
  • 醫藥品受託製造市場:收益額預測 (今後6年份)
  • 疫苗受託製造市場
  • 疫苗受託製造的市場規模 (今後6年份)

第6章 疫苗製造市場質性分析 (今後6年份)

  • 市場趨勢
  • 市場機會
  • 各種法規
  • 市場動態
  • 價值鏈分析
  • 平均價格分析
  • SWOT分析
  • 大環境分析
  • 疫苗與其他的治療方法比較
  • 市場方案
  • 市場未來展望

第7章 表格一覽

第8章 圖的一覽

第9章 分析對象企業、團體的一覽

目錄

The vaccine manufacturing technology and services market has experienced considerable growth over the past decade. Vaccines are a global healthcare success, currently driven by disease burden and the expanding global population. The vaccine contract manufacturing market was valued at US$365.0M in 2015 and is expected to reach US$ XXXX M, at a CAGR of XXXX % during 2016-2021. In the aftermath of a global recession that has affected the bottom line of the major pharmaceutical players, there is currently significant uncertainty within the pharmaceutical industry. Many companies have reduced their capacity, staff levels and R&D activity. However, biologics continue to be an area of increasing interest among pharmaceutical companies. In recent years vaccines manufacturers have benefited from governmental take-up for vaccines designed to target pandemic influenza outbreaks. In the wake of the two major pandemic influenza outbreaks of the last decade (the H5N1 'avian flu' influenza pandemic, and the H1N1 'swine flu' influenza pandemic), immunising against pandemic strains of influenza has become a governmental priority worldwide.

The US was the largest market for Vaccine Contract Manufacturing, accounted for 41.8 % of the global market. The US is home to an increasing number of small biotech companies, thus, presents opportunities for small-scale contract manufacturing services.

Furthermore, increasing costs related to early-stage drug development and testing will further boost the demand for vaccine contract manufacturing in this region.

Our research provides a critical assessment of the vaccine production outsourcing market. Particular emphasis is placed on technological developments and trends in the outsourcing of vaccine production and related services.

image1

image2

image3

Table of Contents

  • Report Summary
  • Introduction to Vaccine Contract Manufacturing Market 2015
  • What information can you expect to gain from this report?
  • Market Segmentation
  • Leading National Market for Vaccine Contract Manufacturing

1. Historical Data

  • 1.1 Vaccine Contract Manufacturing Market 2011
  • 1.2 Vaccine Contract Manufacturing Market 2012
  • 1.3 Vaccine Contract Manufacturing Market 2013
  • 1.4 Vaccine Contract Manufacturing Market 2014

2. Leading Companies in the Vaccine Contract Manufacturing Market

  • 2.1 Baxter BioPharma Solutions
  • 2.2 Boehringer Ingelheim
  • 2.3 Catalent
  • 2.4 Charles River Laboratories
  • 2.5 IDT Biologika GmbH
  • 2.6 Lonza
  • 2.7 Meridian Life Science
  • 2.8 Sigma-Aldrich
  • 2.9 SynCo Bio Partners
  • 2.10 OSO BioPharmaceuticals Manufacturing
  • 2.11 Leading Vaccine Contract Manufacturing Organisations.

3. Vaccine Manufacturing Technologies 2015

  • 3.1 The Global Market for Biosimilar Vaccine Contract Manufacturing in 2015
  • 3.2 New Substrates for Vaccine Production
  • 3.3 Mammalian Cell Lines
  • 3.4 Avian-Derived Cell Lines
  • 3.5 Plant-Based Vaccines
  • 3.6 Insect Egg-Based Production Systems
  • 3.7 Expression Systems and Vectors
  • 3.8 Equipment Trends
  • 3.9 Prefilled Syringes and Vaccines
  • 3.10 Lyophilisation and Vaccine Manufacturing
  • 3.11 Shelf Life Issues of Some H1N1 Vaccine

4. Leading National Markets for Vaccine Contract Manufacturing, 2016-2021

  • 4.1 Asia Vaccine Contract Manufacturing :Regional Forecast 2016-2021
  • 4.2 The India Market Forecast 2016-2021
  • 4.3 The China Market Forecast 2016-2021
  • 4.4 The South Korea Market Forecast 2016-2021
  • 4.5 The Japan Market Forecast 2016-2021
  • 4.6 The Rest of Asia Market Forecast 2016-2021
  • 4.7 The Europe Market Forecast 2016-2021
  • 4.8 The Russia Market Forecast 2016-2021
  • 4.9 The Germany Market Forecast 2016-2021
  • 4.10 The United Kingdom Market Forecast 2016-2021
  • 4.11 The France Market Forecast 2016-2021
  • 4.12 The Italy Market Forecast 2016-2021
  • 4.13 The rest of Europe Market Forecast 2016-2021
  • 4.14 The North America Market Forecast 2016-2021
  • 4.15 The U.S. Market Forecast 2016-2021
  • 4.16 The Canada Market Forecast 2016-2021
  • 4.17 The Latin America Market Forecast 2016-2021
  • 4.18 The Brazil Market Forecast 2016-2021
  • 4.19 The Mexico Market Forecast 2016-2021
  • 4.20 The Rest of Latin America Market Forecast 2016-2021
  • 4.21 The Rest of the World Market Forecast 2016-2021

5. Vaccine Manufacturing Market 2016-2021

  • 5.1 Outsourcing in the Pharmaceutical and Biotechnology Industry
  • 5.2 Contract Manufacturing Organisations
  • 5.3 The Pharmaceutical Contract Manufacturing Market: Revenue Forecast 2016-2021
  • 5.4 Contract Manufacturing Market for Vaccines 2016-2026
  • 5.5 Market Size for Contract Manufacturing of Vaccines 2016-2021

6. Qualitative Analysis for Vaccine Manufacturing Market 2016-2021

  • 6.1 Market Trends
  • 6.2 Market Opportunities
  • 6.3 Various Regulations
  • 6.4 Market Dynamics
  • 6.5 Value Chain Analysis
  • 6.6 Average Pricing Analysis
  • 6.7 SWOT Analysis
  • 6.8 Pestle Analysis
  • 6.9 Comparison between vaccines and Other Treatment
  • 6.10 Market Scenario
  • 6.11 Future Market Outlook

7. List of Tables

  • Table 1 Baxter BioPharma Solutions.: Historical Data ($m, AGR%), 2011-2014
  • Table 2 Boehringer Ingelheim: Historical Sales ($m, AGR%), 2011-2014
  • Table 3 Catalent: Historical Sales ($m, AGR%), 2011-2014
  • Table 4 Coherus BioSciences, Inc: Historical Sales ($m, AGR%), 2011-2014
  • Table 5 Charles River Laboratories: Historical Sales ($m, AGR%), 2011-2014
  • Table 6 IDT Biologika GmbH: Historical Sales ($m, AGR%), 2011-2014
  • Table 7 Lonza: Historical Sales ($m, AGR%), 2011-2014
  • Table 8 Meridian Life Science: Historical Sales ($m, AGR%), 2011-2014
  • Table 9 Sigma-Aldrich.: Historical Sales ($m, AGR%), 2011-2014
  • Table 10 SynCo Bio Partners, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 11 OSO BioPharmaceuticals Manufacturing, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 12 Baxter BioPharma Solutions, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 13 Boehringer Ingelheim, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 14 Catalent Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 15 Adalimumab Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 16 Coherus BioSciences Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 17 Market Share Analysis by Major Compound/Clas, 2015 (%)
  • Table 18 Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 19 India Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 20 China Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 21 South Korea Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 22 Japan Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 23 Rest of Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 24 Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 25 Russia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 26 Germany Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 27 United Kingdom Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 28 France Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 29 Italy Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 30 Rest of Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 31 North America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 32 The U.S. Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 33 Canada Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 34 Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 35 Brazil Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 36 Mexico Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 37 Rest of the Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 38 Rest of the World Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 39 Market Share Analysis by Country, 2015 (%)
  • Table 40 SWOT Analysis of the Vaccine Manufacturing Technologies Market
  • Table 41 Pestle Analysis of the Vaccine Manufacturing Technologies Market

8. Lists of Figures

  • Figure 1 Global Vaccine Contract Manufacturing Market Segmentation Overview, 2015
  • Figure 2 Pfizer, Inc.: Historical Sales ($m, AGR%), 2011-2014
  • Figure 3 Novartis: Historical Sales ($m, AGR%), 2011-2014
  • Figure 4 Allergan plc: Historical Sales ($m, AGR%), 2011-2014
  • Figure 5 Coherus Biosciences, Inc.: Historical Sales ($m, AGR%), 2011-2014
  • Figure 6 Biocon: Historical Sales ($m, AGR%), 2011-2014
  • Figure 7 Dr. Reddy's Laboratories Ltd.: Historical Sales ($m, AGR%), 2011-2014
  • Figure 8 Boehringer Ingelheim GmbH: Historical Sales ($m, AGR%), 2011-2014
  • Figure 9 Intas Pharmaceuticals Limited: Historical Sales ($m, AGR%), 2011-2014
  • Figure 10 Celltrion, Inc.: Historical Sales ($m, AGR%), 2011-2014
  • Figure 11 Global Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 12 Rituxiab Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 13 Infliximab Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 14 Abciximab Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 15 Transtuzumab Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 16 Adalimumab Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 17 Bevacizumab Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 18 Market Share Analysis, 2015 (%)
  • Figure 19 Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 20 India Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 21 China Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 22 South Korea Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 23 Japan Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 24 Rest of Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 25 Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 26 Russia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 27 Germany Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 28 United Kingdom of Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 29 France Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 30 Italy Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 31 Rest of Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 32 North America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 33 The U.S. Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 34 Canada Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 35 Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 36 Brazil Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 37 Mexico of Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 38 Rest of Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 39 Rest of the World Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 40 Market Share Analysis by Country (%)

9 Companies and Other Organizations Mentioned

  • Baxter BioPharma Solutions
  • Boehringer Ingelheim
  • Catalent
  • Charles River Laboratories
  • IDT Biologika GmbH
  • Lonza
  • Meridian Life Science
  • Sigma-Aldrich
  • SynCo Bio Partners
  • OSO BioPharmaceuticals Manufacturing
  • EMA (European Medicines Agency)
  • FDA (US Food and Drug Administration)
  • Merck & Co.
  • MHLW (Ministry of Health, Labour, and Welfare)
  • MHRA (Medicines and Healthcare Products Regulatory Agency)
  • NICE (the National Institute for Health and Care Excellence)
  • Pfizer, Inc.
  • Novartis AG
  • Reliance Life Sciences
  • Allergan plc
  • Coherus BioSciences, Inc.
  • Biocon
  • Dr. Reddy's Laboratories Ltd.
  • BioXpress Therapeutics SA
  • Intas Pharmaceuticals Limited
  • BIOCAD
  • Genor BioPharma Co. Ltd
  • Celltrion, Inc.
  • The list continues....
Back to Top